Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 17 Mar 2026 for Cytokinetics INC. Read the official filing
Filing timeline
BuySaleJeffrey Hessekiel
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jeffrey Hessekiel: trading record in brief
Jeffrey Hessekiel (senior executive) discloses dealings in 2 companies, chiefly Exelixis, Inc. and Cytokinetics Inc. In total, 40 filings cover trades dated from 11 February 2016 to 15 March 2026.
No open-market purchase appears, only 10 sales worth €5.0M. Outside the open market, there are 25 share grants and 5 option exercises.
The latest filing, published on 17 March 2026, reports a share grant in Cytokinetics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeffrey Hessekiel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
20,646 shares0Common StockSEC:0001061983-26-000022:0
87,297 shares0Common StockSEC:0001061983-25-000036:0
34,035 shares@ US$44.659.6% of flowCommon StockSEC:0000939767-25-000078:0
154,070 shares0Common StockSEC:0000939767-25-000052:0
52,192 shares0Common StockSEC:0000939767-25-000041:0
18,134 shares@ US$35.004.3% of flowCommon StockSEC:0000939767-25-000025:0
118,780 shares0Common StockSEC:0000939767-25-000007:0
129,314 shares@ US$18.8016.3% of flowCommon StockSEC:0000939767-24-000165:0
14,672 shares@ US$35.053.4% of flowCommon StockSEC:0000939767-24-000160:0
50,000 shares@ US$34.1311.0% of flowCommon StockSEC:0000939767-24-000156:0
25,000 shares@ US$28.394.6% of flowCommon StockSEC:0000939767-24-000152:0
25,000 shares@ US$26.384.2% of flowCommon StockSEC:0000939767-24-000132:0
20,000 shares@ US$24.413.1% of flowCommon StockSEC:0000939767-24-000131:0
80,000 shares@ US$24.4112.6% of flowCommon StockSEC:0000939767-24-000124:0
7,240 shares@ US$20.991.0% of flowCommon StockSEC:0000939767-24-000068:0
63,350 shares0Common StockSEC:0000939767-24-000031:0
71,418 shares0Common StockSEC:0000939767-24-000018:0
25,000 shares@ US$23.013.8% of flowCommon StockSEC:0000939767-23-000123:0
25,000 shares@ US$22.013.5% of flowCommon StockSEC:0000939767-23-000120:0
57,900 shares0Common StockSEC:0000939767-23-000103:0
7,177 shares@ US$21.511.0% of flowCommon StockSEC:0000939767-23-000088:0
55,710 shares@ US$14.745.3% of flowCommon StockSEC:0000939767-23-000081:0
4,940 shares@ US$19.180.6% of flowCommon StockSEC:0000939767-23-000053:0
79,719 shares0Common StockSEC:0000939767-23-000041:0
27,860 shares@ US$14.742.7% of flowCommon StockSEC:0000939767-23-000030:0
25 of 40 declarations
